<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinvest</journal-id><journal-title-group><journal-title xml:lang="ru">Качественная клиническая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2588-0519</issn><issn pub-type="epub">2618-8473</issn><publisher><publisher-name>ООО «Издательство ОКИ</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">clinvest-20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КАЧЕСТВО ЖИЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>QUALITY OF LIFE</subject></subj-group></article-categories><title-group><article-title>Слово к Консенсусу по QALY</article-title><trans-title-group xml:lang="en"><trans-title>Toward a Consensus on the QALY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Drummond</surname><given-names>Michael</given-names></name><name name-style="western" xml:lang="en"><surname>Drummond</surname><given-names>Michael</given-names></name></name-alternatives><bio xml:lang="ru"><p>DPhil,</p><p>York, UK</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Brixner</surname><given-names>Diana</given-names></name><name name-style="western" xml:lang="en"><surname>Brixner</surname><given-names>Diana</given-names></name></name-alternatives><bio xml:lang="ru"><p>BSPharm, PhD,</p><p>Salt Lake City, Utah, USA</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Gold</surname><given-names>Marthe</given-names></name><name name-style="western" xml:lang="en"><surname>Gold</surname><given-names>Marthe</given-names></name></name-alternatives><bio xml:lang="ru"><p>MD, MPH,</p><p>New York, NY, USA</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Kind</surname><given-names>Paul</given-names></name><name name-style="western" xml:lang="en"><surname>Kind</surname><given-names>Paul</given-names></name></name-alternatives><bio xml:lang="ru"><p>York, UK</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>McGuire</surname><given-names>Alistair</given-names></name><name name-style="western" xml:lang="en"><surname>Mcguire</surname><given-names>Alistair</given-names></name></name-alternatives><bio xml:lang="ru"><p>PhD,</p><p>London, UK</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Nord</surname><given-names>Erik</given-names></name><name name-style="western" xml:lang="en"><surname>Nord</surname><given-names>Erik</given-names></name></name-alternatives><bio xml:lang="ru"><p>PhD,</p><p>Oslo, Norway</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вилюм</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vilum</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="en"><p>ассистент, </p><p>Санкт-Петербург</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоусов</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Belousov</surname><given-names>D. Yu.</given-names></name></name-alternatives><bio xml:lang="en"><p>генеральный директор,</p><p>г. Москва</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>University of York</institution><country>Великобритания</country></aff><aff xml:lang="en"><institution>University of York</institution><country>United Kingdom</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>University of Utah</institution><country>Соединённые Штаты Америки</country></aff><aff xml:lang="en"><institution>University of Utah</institution><country>United States</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>City University of New York Medical School</institution><country>Соединённые Штаты Америки</country></aff><aff xml:lang="en"><institution>City University of New York Medical School</institution><country>United States</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>London School of Economics</institution><country>Великобритания</country></aff><aff xml:lang="en"><institution>London School of Economics</institution><country>United Kingdom</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Norwegian Institute of Public Health</institution><country>Норвегия</country></aff><aff xml:lang="en"><institution>Norwegian Institute of Public Health</institution><country>Norway</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет имени акад. И.П. Павлова, Санкт-Петербург; Санкт-Петербургский государственный университет, Санкт-Петербург</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Pavlov State Medical University of St. Peterburg; National Medical and Surgical Center of the N.I. Pirogov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ООО "Центр фармакоэкономических исследований", г. Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>LLC "Center for Pharmacoeconomics Research", Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>05</month><year>2018</year></pub-date><volume>0</volume><issue>2</issue><fpage>98</fpage><lpage>103</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Drummond M., Brixner D., Gold M., Kind P., McGuire A., Nord E., Вилюм И.А., Белоусов Д.Ю., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Drummond M., Brixner D., Gold M., Kind P., McGuire A., Nord E., Вилюм И.А., Белоусов Д.Ю.</copyright-holder><copyright-holder xml:lang="en">Drummond M., Brixner D., Gold M., Kind P., Mcguire A., Nord E., Vilum I.A., Belousov D.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinvest.ru/jour/article/view/20">https://www.clinvest.ru/jour/article/view/20</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>распределение ресурсов</kwd><kwd>качество жизни</kwd><kwd>оценка состояния здоровья</kwd><kwd>resource allocation</kwd><kwd>quality of life</kwd><kwd>health state valuation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Nord E., Daniels N., Kamlet M. QALYs: some challenges. Value Health 2008;12(Suppl. 1):S10-5.</mixed-citation><mixed-citation xml:lang="en">Nord E., Daniels N., Kamlet M. QALYs: some challenges. Value Health 2008;12(Suppl. 1):S10-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.</mixed-citation><mixed-citation xml:lang="en">Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fryback D.G., Palta M., Cherepov D., et al. Cross-walks among five self-reported summary health utility indexes: progress and prospects. Med Decis Making 2008;28:E24.</mixed-citation><mixed-citation xml:lang="en">Fryback D.G., Palta M., Cherepov D., et al. Cross-walks among five self-reported summary health utility indexes: progress and prospects. Med Decis Making 2008;28:E24.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rawlins M.D., Culyer A.J. National institute for clinical excellence and its value judgments. BMJ 2004;329:224-7.</mixed-citation><mixed-citation xml:lang="en">Rawlins M.D., Culyer A.J. National institute for clinical excellence and its value judgments. BMJ 2004;329:224-7.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Aspinall S.L., Good C.B., Glassman P.A., Valentino M.A. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veteran Affairs. Med Care 2005;43(Suppl. 7):S20-6.</mixed-citation><mixed-citation xml:lang="en">Aspinall S.L., Good C.B., Glassman P.A., Valentino M.A. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veteran Affairs. Med Care 2005;43(Suppl. 7):S20-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wu W.K., Sause R.B., Zacker C. Use of health-related quality of life information in managed care formulary decision-making. Res Social Adm Pharm 2005;1:579-98.</mixed-citation><mixed-citation xml:lang="en">Wu W.K., Sause R.B., Zacker C. Use of health-related quality of life information in managed care formulary decision-making. Res Social Adm Pharm 2005;1:579-98.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gold M.R., Sofaer S., Siegelberg T. Medicare and CEA; time to ask the taxpayers. Health Aff (Millwood) -2007;5:1399-406.</mixed-citation><mixed-citation xml:lang="en">Gold M.R., Sofaer S., Siegelberg T. Medicare and CEA; time to ask the taxpayers. Health Aff (Millwood) -2007;5:1399-406.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sofaer S., Bryan S., Gold M.R. Decision-makers’ attitudes toward cost-effectiveness analysis. Abstract. Academy Health, Orlando, July 5, 2007.</mixed-citation><mixed-citation xml:lang="en">Sofaer S., Bryan S., Gold M.R. Decision-makers’ attitudes toward cost-effectiveness analysis. Abstract. Academy Health, Orlando, July 5, 2007.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Neumann P.J., Palmer J.A., Daniels N., et al. Panel on integrating cost-effectiveness considerations into health policy decisions. Am J Manag Care 2008;14:185-8.</mixed-citation><mixed-citation xml:lang="en">Neumann P.J., Palmer J.A., Daniels N., et al. Panel on integrating cost-effectiveness considerations into health policy decisions. Am J Manag Care 2008;14:185-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">American College of Physicians. Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 2008;149:956- 61.</mixed-citation><mixed-citation xml:lang="en">American College of Physicians. Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 2008;149:956- 61.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
